Funder
Concern Foundation
University of California, Los Angeles
National Institutes of Health
University of California, Davis
National Cancer Institute
Reference73 articles.
1. Targeting metastatic cancer;Ganesh;Nat. Med.,2021
2. Defining the Hallmarks of Metastasis;Welch;Cancer Res.,2019
3. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma;Palanisamy;Nat. Med.,2010
4. Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma;Chen;Eur. J. Surg. Oncol.,2011
5. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model;Kinkade;J. Clin. Invest.,2008